HawkScreener
Register Sign In
Dashboard Screener Heatmap Compare Sign In

CCJ

Cameco Corporation (NYSE)

Energy — Uranium

Cameco Corporation provides uranium for the generation of electricity in the Americas, Europe, and Asia. It operates in three segments: Uranium, Fuel Services, and Westinghouse. The Uranium segment engages in the exploration for, mining, milling, purchase, and sale of uranium concentrate. Its Fuel Services segment is involved in the refining, conversion, and fabrication of uranium concentrate, as well as purchase and sale of conversion services. The Westinghouse segment operates as a nuclear reactor technology original equipment manufacturer and a provider of products and services to commercial utilities and government agencies. It also provides outage and maintenance, engineering support, instrumentation and controls equipment, and plant modification services, as well as components and parts to nuclear reactors. The company sells its uranium and fuel products and services to nuclear utilities. Cameco Corporation was incorporated in 1987 and is headquartered in Saskatoon, Canada.

Buy 1.8 / 5 10 analysts
$90.57
+$1.89 (+2.13%)
Target: $132.43 (46.2%)
Sign in to add CCJ to a watchlist or set price alerts.

Price History

52-Week Range

Fundamentals

Market Cap$42.42B
P/E Ratio (TTM)92.75
Forward P/E52.04
EPS (TTM)$1.05
Dividend Yield0.18%
Profit Margin18.39%
Revenue Growth7.10%
ROE9.60%
Debt/Equity14.31
Recommendation Buy 1.8
Analyst Target$132.43
Analysts10
Indexes NYSE

Technical Indicators

RSI (14)53.7
Beta0.98
SMA 20-
SMA 40-
52-Week High$135.24
52-Week Low$68.96
50-Day Avg$110.82
200-Day Avg$104.03
Avg Volume$3.37M
Volume$2.92M

Performance Analysis

NEUTRAL

CCJ presents a mixed picture with both positive and negative indicators.

~ Trading at 33% of its 52-week range.
~ RSI at 53.7 is in neutral territory.
- Price is below both the 50-day and 200-day moving averages — in a downtrend.
- P/E of 92.8 is elevated — the market expects high growth or it may be overvalued.
~ Modest revenue growth of 7.1% year-over-year.
+ Wall Street consensus is "Buy" from 10 analysts.
+ Average analyst target of $132.43 implies 46.2% upside.

Recent News

Loading news...
Sign in for full analysis Unlock insider trading data, options chain, news feed, and more.
Sign In

Last updated: Jul 02, 2026 13:02 UTC

Back to Screener Export Report